Strategic partnerships Sevaro has recently formed a partnership with the National Specialty Care Access Coalition (NSCAC), signaling open opportunities to collaborate with hospital networks and specialty care programs. This suggests a path to co-sell or integrate services with other healthcare organizations aligned to neonatal/stroke and neurology care.

Growth leadership New key leadership appointments in 2026, including Chief Technology Officer and Head of Growth, indicate a strategic emphasis on technology-enabled growth, market expansion, and scalable adoption of teleneurology solutions that you can target with value propositions around faster deployments and measurable outcomes.

Funding momentum With a Series B of 39 million USD and investors like Valtruis and Intermountain Ventures, Sevaro demonstrates strong financial backing and growth trajectory, creating an opportunity to discuss enterprise-scale deployments, multi-site contracts, and long-term partnerships with risk-sharing or outcome-based models.

Clinical- tech leverage Powered by Synapse AI and a tech stack spanning MongoDB, Splunk, Twilio and Atlassian, Sevaro emphasizes rapid imaging reviews, reduced door-to-needle times, and streamlined workflows. This provides a compelling rationale to position complementary hardware, analytics, or integration services to hospital IT and anesthesia/neuro teams.

Market positioning Recognition on CB Insights list of promising digital health startups and a 25-50M revenue scale place Sevaro as a credible disruptor in teleneurology. Use this to target mid-to-large hospital systems seeking innovation, digital transformation, and improved stroke outcomes with quantifiable ROI.